Sponsored: After COVID-19, are we better prepared for the next pandemic?

Next Question with Katie Couric

On this sponsored episode of Next Question with Katie Couric, Katie sits down with Dr. Julie L. Gerberding, the executive vice president and chief patient officer of the biopharmaceutical company Merck. As a company with a long legacy of research in infectious disease, Merck has been in the thick of the COVID crisis, mobilizing its scientific expertise to help address the pandemic. Katie and Dr. Gerberding talk about the waning months of this historic pandemic, the lingering concerns about vaccinations and variants, COVID’s lasting impact on public health and how we can better prepare for emerging diseases. Merck is a partner of Katie Couric Media.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Hosted on Acast. See acast.com/privacy for more information.

More description

On this sponsored episode of Next Question with Katie Couric, Katie sits down with Dr. Julie L. Gerberding, the executive vice president and chief patient officer of the biopharmaceutical company Merck. As a company with a long legacy of research in infectious disease, Merck has been in the thick of the COVID crisis, mobilizing its scientific expertise to help address the pandemic. Katie and Dr. Gerberding talk about the waning months of this historic pandemic, the lingering concerns about vaccinations and variants, COVID’s lasting impact on public health and how we can better prepare for emerging diseases. Merck is a partner of Katie Couric Media.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Hosted on Acast. See acast.com/privacy for more information.

2021-06-08 41 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.